Concepedia

Karen Stoner

KS

3

Publications

417

Citations

3

H-Index

2007

Active since

Affiliations

Procter & Gamble (United States)(Current)

Oregon Health & Science University

KU Leuven

Procter & Gamble (United Kingdom)

Karen Stoner is an author at Procter & Gamble (United States) specializing in bone health, orthopaedics, and osteoporosis.

Top concepts

Publications per year

2007–2012

3

Publications

3

Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study

Piotr Krzeski, Chris Buckland‐Wright, Géza Bálint et al. · Arthritis Research & Therapy · 2007 · 198 citations · Full text

Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study

Steven Boonen, Eric Orwoll, Dietrich Wenderoth et al. · Journal of Bone and Mineral Research · 2008 · 188 citations

, , +11

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study

Steven Boonen, R Lorenc, Dietrich Wenderoth et al. · Bone · 2012 · 31 citations

, , +6

Rows per page

1–3 of 3